P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression
- 1 September 2001
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 98 (1) , 103-108
- https://doi.org/10.1016/s0301-2115(00)00562-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prognostic significance of p53, bcl-2, vimentin, and S 100 protein-positive langerhans cells in endometrial carcinomaHuman Pathology, 1998
- Prognostic Value of p53 and Proliferating Cell Nuclear Antigen Expression in Endometrial CarcinomaGynecologic Oncology, 1996
- The prognostic significance of surgical staging for carcinoma of the endometriumGynecologic Oncology, 1992
- Tumor Suppressor GenesScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Evaluation of unfavorable histologic subtypes in endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1990
- Peritoneal cytology in patients with endometrial carcinomaGynecologic Oncology, 1988
- Prognostic Factors in Early Carcinoma of the EndometriumAmerican Journal of Clinical Oncology, 1987
- Risk factors and recurrent patterns in Stage I endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Carcinoma of the endometrium: Effect of stage and grade on survivalCancer, 1978